Document is current
Any future updates will be listed below
-
Authors
Gerischer, Lea https://orcid.org/0000-0001-5746-068X
Doksani, Paolo https://orcid.org/0009-0009-5381-5995
Hoffmann, Sarah https://orcid.org/0000-0001-9549-2594
Meisel, Andreas https://orcid.org/0000-0001-7233-5342
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Accepted: 15 December 2024
First Online: 27 January 2025
Declarations
:
: Open Access funding enabled and organised by Projekt DEAL.
: Concept and planning of the review: L.G. and A.M.; writing of first draft: L.G.; figures: P.D.; and critical revision of the manuscript: all authors. All authors read and approved the final manuscript.
: L.G. reports no conflicts of interest. P.D. received speaker´s honoraria from Alexion and UCB. S.H. received speaker´s honoraria and honoraria for attendance at advisory boards from Alexion, argenx, Roche and UCB. A. M. received speaker or consultancy honoraria or financial research support (paid to his institution) from Alexion, Argenx, Axunio, Destin, Grifols, Hormosan Pharma, Janssen, Merck, Octapharma, UCB and Xcenda. He serves as member of the medical advisory board of the German Myasthenia Gravis Society.
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analysed for this review article; data that support the findings referenced in this article can be found in their corresponding referenced original study.
: Not applicable.
